Nantahala Capital Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.85M | Sell |
|
|||||
|
2023
Q1 | $1.32M | Sell |
|
|||||
|
2022
Q4 | $2.07M | Buy |
|
|||||
|
2022
Q3 | $1.95M | Sell |
|
|||||
|
2022
Q2 | $1.96M | Buy |
|
|||||
|
2022
Q1 | $7.36M | Buy |
|
|||||
|
2021
Q4 | $13.4M | Buy |
|
|||||
|
2021
Q3 | $12.1M | Sell |
|
|||||
|
2021
Q2 | $11.7M | Sell |
|
|||||
|
2021
Q1 | $13.6M | Sell |
|
|||||
|
2020
Q4 | $15.5M | Sell |
|
|||||
|
2020
Q3 | $22.1M | Sell |
|
|||||
|
2020
Q2 | $29.6M | Buy |
|
|||||
|
2020
Q1 | $13.1M | Hold |
|
|||||
|
2019
Q4 | $21.8M | Hold |
|
|||||
|
2019
Q3 | $21.9M | Hold |
|
|||||
|
2019
Q2 | $19.5M | Buy |
|
|||||
|
2019
Q1 | $21.4M | Buy |
|
|||||
|
2018
Q4 | $18.9M | Hold |
|
|||||
|
2018
Q3 | $24.2M | Buy |
|
|||||
|
2018
Q2 | $23.4M | Buy |
|
|||||
|
2018
Q1 | $18.3M | Hold |
|
|||||
|
2017
Q4 | $9.98M | Buy |
|
|||||
|
2017
Q3 | $7.9M | Buy |
|
|||||
|
2017
Q2 | $6.13M | Buy |
|